期刊
GENE THERAPY
卷 12, 期 18, 页码 1360-1368出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.gt.3302557
关键词
immunotoxin; Shiga toxin B-subunit; retrograde transport; immunotherapy; tumor targeting
The immunotoxin approach is based on the use of tumor-targeting ligands or antibodies that are linked to the catalytic ( toxic) moieties of bacterial or plant protein toxins. In this review, we first discuss the current state of clinical development of immunotoxin approaches describing the results obtained with the two toxins most frequently used: diphtheria and Pseudomonas toxin-derived proteins. In the second part of the review, a novel concept will be presented in which the roles are inverted: nontoxic receptor-binding toxin moieties are used for the targeting of therapeutic and diagnostic compounds to cancer or immune cells. The cell biological basis of these novel types of toxin-based therapeutics will be discussed, and we will summarize ongoing preclinical and clinical testing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据